CEChristian Enzensberger

Christian Enzensberger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christian Enzensberger has a total of 119 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Serologische microRNA als potenzieller Biomarker bei Schwangeren mit late-onset Präeklampsie (ROMY-Studie)

    by O Graupner, J Maurer, L Lecker, B Klein, S Karim-Payab, C Enzensberger, E Stickeler

    Zielsetzung MicroRNAs (miRNA) sind Regulatoren zellulärer Prozesse einschließlich (Anti-)Angiogenese und Differenzierung von Trophoblastzellen. Sie spielen eine Rolle in der Pathophysiologie Plazenta-assoziierter Erkrankungen wie der Präeklampsie (PE). Ziel dieser Studie ist es, das Potential der miRNA als komplementären Biomarker in einem definierten PE – Kollektiv (late-onset: ≥34+0 SSW) zu untersuchen. Material und Methoden Diese Interimsanalyse einer monozentrischen, prospektiven Kohorten-Studie vergleicht Patientinnen mit bestätigter late-onset PE (n=8) mit gesunden Kontrollpatientinnen (n=8). Dabei wurde die Konzentration der häufigsten PE-assoziierten miRNA im Serum untersucht (miR-210, miR-518b, miR-221). PE-Schwangerschaften wurden nochmals in Bezug auf die sFlt-1 (soluble fms-like tyrosine kinase-1) / PlGF (placental growth factor) – Ratio in angiogen (≥110) und non-angiogen (<110) unterteilt. Aufgrund der niedrigen Fallzahl wurde eine rein deskriptive statistische Analyse durchgeführt. Ergebnisse Das mittlere Gestationsalter in der PE- und Kontrollgruppe betrug 37+0. SSW. Folgende mittlere Konzentrationen (delta CT) konnten in der PE-Gruppe vs. Kontrollgruppe nachgewiesen werden: miR-210 (7,76 vs. 8,00), miR-518b (9,39 vs. 10,11) und miR-221 (13,41 vs. 12,06). Eine Unterteilung in angiogene (sFlt-1/PlGF <110) vs. non-angiogene PE (sFlt-1/PlGF ≥110) erbrachte folgende Konzentrationsunterschiede innerhalb der PE-Gruppe: miR-210 (7,14 vs. 8,13), miR-518b (9,68 vs. 9,21) und miR-221 (12,19 vs. 14,14). Zusammenfassung Es zeigten sich keine signifikanten miRNA-Konzentrationsunterschiede zwischen late-onset PE und gesunden Patientinnen. Inwieweit sich jedoch Konzentrationsunterschiede in Fällen mit early-onset PE (und bekanntermaßen höherem Ausmaß einer anti-angiogenen Dysbalance) zeigen, gilt es in künftigen Studien mit großer Fallzahl zu klären. Article published online: 11 October 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Serologische microRNA als potenzieller Biomarker bei Schwangerschaften mit später fetaler Wachstumsrestriktion (ROMY-Studie)

    by O Graupner, J Maurer, L Lecker, B Klein, S Karim-Payab, E Stickeler, C Enzensberger

    Zielsetzung MicroRNAs (miRNA) sind Regulatoren zellulärer Prozesse wie der plazentaren (Anti-)Angiogenese. Sie spielen eine Rolle in der Pathophysiologie Plazenta-assoziierter Erkrankungen wie der fetalen Wachstumsrestriktion (FGR). Ziel dieser Studie ist es, das Potential der miRNA als komplementären Biomarker in einem definierten FGR – Kollektiv (late-onset: ≥32+0 SSW) zu untersuchen. Material und Methoden Diese Interimsanalyse einer monozentrischen, prospektiven Kohorten-Studie vergleicht Patientinnen mit bestätigter late-onset FGR (n=8) mit gesunden Kontrollpatientinnen (n=8). Dabei wurde die Konzentration der häufigsten FGR-assoziierten miRNA im Serum untersucht (miR-185, miR-210, miR-424, miR-518b). FGR-Schwangerschaften wurden nochmals hinsichtlich der Cerebroplazentaren Ratio (CPR) in Fälle mit einer CPR < bzw. ≥ 5. Perzentile unterteilt. Aufgrund der niedrigen Fallzahl wurde eine rein deskriptive statistische Analyse durchgeführt. Ergebnisse Das mittlere Gestationsalter betrug 37+3 SSW in der late-onset FGR-Gruppe und 37+0 SSW in der Kontrollgruppe. Folgende mittlere Konzentrationen (delta CT) konnten in der FGR- vs. Kontrollgruppe nachgewiesen werden: miR-185-5p (5,81 vs. 5,42), miR-210-3p (8,51 vs. 8,00), miR-424-3p (8,25 vs. 8,01), miR-424-5p (6,80 vs. 6,38) und miR-518b (9,86 vs. 10,11). Folgende Konzentrationsunterschiede zeigten sich nach Unterteilung FGR-Gruppe in CPR <5. P. vs. CPR ≥5. P.: miR-185-5p (5,86 vs. 5,64), miR-210-3p (8,45 vs. 8,69), miR-424-3p (8,49 vs. 7,52), miR-424-5p (6,84 vs. 6,68) und miR-518b (9,92 vs. 9,69). Zusammenfassung Es zeigten sich keine signifikanten miRNA-Konzentrationsunterschiede zwischen late-onset FGR-Fällen und Kontrollen. Inwieweit sich jedoch Konzentrationsunterschiede in Fällen mit early-onset FGR (und bekanntermaßen höherem Ausmaß einer anti-angiogenen Dysbalance) zeigen, gilt es in künftigen Studien mit großer Fallzahl zu klären. Article published online: 11 October 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    Bowel Obstruction Due to Stenotic Sigmoid Colon Cancer in a 32-Year-Old Patient Presenting in the Third Trimester of Pregnancy: A Case Report of an Interval Surgical Approach

    by Daniel Antonio Morales Santana, Zoltan Czigany, Franziska A. Meister, Georg J. Wiltberger, Rebecca Caspers, Christian Enzensberger, Elmar Stickeler, Ulf P. Neumann, Andreas Lambertz

    Unusual clinical course Colorectal cancer among pregnant women is a rare entity. If colon cancer is suspected during pregnancy, the diagnosis is a therapeutic challenge that should be managed by a multidisciplinary team of specialists. Standardized therapeutic models do not exist. In this article we present a case of a pregnant patient with stenotic sigmoid colon adenocarcinoma. We describe the interdisciplinary treatment and the 2-step surgical approach used during pregnancy. A 32-year-old women in week 28.8 of pregnancy was admitted to the Department of Gynecology and Obstetrics, meeting the standard pregnancy criteria of constipation. After a week of unsuccessful conservative treatment, the patient underwent magnetic resonance imaging (MRI), which disclosed a stenosed segment in the sigmoid colon. After an emergency colonoscopy with biopsy sampling, histological analysis confirmed sigmoid adeno-carcinoma. In a multidisciplinary consultation of specialists, in which neonatological and oncological aspects were considered, a 2-step surgical plan was established. In the first step (gestational week 29.8), a loop trans-verse colostomy with intestinal decompression was performed. In the second step (gestational week 32.8), an elective primary caesarean section followed by open oncological sigmoid resection was performed. No postoperative complications occurred in either step. The neonate was healthy and had a birth weight appropriate for the gestational age. In cases of colorectal cancer during pregnancy, staged surgical approaches should be considered to reduce maternal and fetal morbidity.


  • Open Access

    Atrial and Ventricular Deformation Analysis in Normal Fetal Hearts Using Two-Dimensional Speckle Tracking Echocardiography

    by Markus Meister, Roland Axt-Fliedner, Oliver Graupner, Viktoria Kuhn, Aline Wolter, Malena Götte, Christian Enzensberger

    Objective: Two-dimensional speckle tracking echocardiography (2D-STE)-based strain values of the left and the right ventricle have been established; however, less is known about atrial deformation. The aim of our study was to assess both atrial strain and ventricular strain using 2D-STE in a cardiac 4-chamber view and to investigate the effect of possible influencing factors such as gestational age. Methods: Fetal echocardiography was performed on a Toshiba Aplio 500 ultrasound system. Based on an apical or basal 4-chamber view of the fetal heart, left and right ventricular longitudinal peak systolic strain (LVLPSS and RVLPSS) as well as left and right atrial longitudinal peak systolic strain (LALPSS and RALPSS) were assessed by 2D-STE. Results: A total of 101 healthy fetuses were included. The mean gestational age (GA) was 26.0 ± 5.6 weeks. GA was significantly positively correlated (p < 0.05) with LVLPSS and RVLPSS and significantly negatively correlated (p < 0.05) with LALPSS and RALPSS. The mean values for LVLPSS and RVLPSS were −17.44 ± 2.29% and −16.89 ± 1.72%. The mean values for LALPSS and RALPSS were 34.09 ± 4.17% and 35.36 ± 2.90%. Conclusion: Ventricular and atrial deformation analysis in 2D-STE was technically feasible and showed comparable values to current data. For future research on myocardial function (MF) of the fetus, considering GA as an influencing factor for deformation analysis seems to be adequate. Especially, atrial deformation analysis allows the assessment of diastolic myocardial function. Further research needs to clarify the clinical meaning of these myocardial deformation indices in fetuses at risk.


  • Open Access

    Induction of left ventricular hypoplasia by occluding the foramen ovale in the fetal lamb

    by Flora Y. Wong, Alex Veldman, Arun Sasi, Mark Teoh, Andrew Edwards, Yuen Chan, Oliver Graupner, Christian Enzensberger, Roland Axt-Fliedner, Mary Jane Black, et al.

    Disturbed fetal haemodynamics often affects cardiac development and leads to congenital cardiac defects. Reduced left ventricular (LV) preload in the fetus may result in hypoplastic LV, mitral and aortic valve, mimicking a moderate form of hypoplastic left heart complex. We aimed to induce LV hypoplasia by occluding the foramen ovale (FO) to reduce LV preload in the fetal sheep heart, using percutaneous trans-hepatic catheterisation. Under maternal anaesthesia and ultrasound guidance, hepatic venous puncture was performed in six fetal lambs (0.7–0.75 gestation). A coronary guidewire was advanced into the fetal inferior vena cava, right and left atrium. A self-expandable stent was positioned across the FO. An Amplatzer Duct Occluder was anchored within the stent for FO occlusion. Euthanasia and post-mortem examination was performed after 3 weeks. Nine fetuses were used as age-matched controls. Morphometric measurements and cardiac histopathology were performed. Compared with controls, fetal hearts with occluded FO had smaller LV chamber, smaller mitral and aortic valves, lower LV-to-RV ratio in ventricular weight and wall volume, and lower number of LV cardiomyocyte nuclei. We conclude that fetal FO occlusion leads to a phenotype simulating LV hypoplasia. This large animal model may be useful for understanding and devising therapies for LV hypoplasia.


  • Bedeutung der sFlt-1/PIGF-Ratio für die Prädiktion des perinatalen Outcome in Zwillingsschwangerschaften

    by A Karge, B Kuschel, S Flechsenhar, A Seiler, B Haller, Ju Ortiz, S Lobmaier, R Axt-Fliedner, C Enzensberger, K Abel, et al.

    Einleitung: Die soluble fms-like tyrosine kinase-1 (sFlt-1)/placental growth factor (PlGF)-Ratio ist ein hilfreicher Marker in der Diagnosestellung der Präeklampsie (PE). Bei Einlingsschwangerschaften mit PE ist eine erhöhte sFlt-1/PIGF-Ratio mit einem adversen perinatalen Outcome (APO) assoziiert. Der Stellenwert der sFlt-1/PIGF-Ratio für die APO-Prädiktion bei Zwillingsschwangerschaften ist unklar. Ziel der Arbeit ist es, die Performance der sFlt-1/PIGF-Ratio bezüglich der APO-Prädiktion bei Zwillingsschwangerschaften mit Verdacht auf eine PE und/oder ein HELLP-Syndrom zu evaluieren. Material/Methode: Es handelt sich um eine retrospektive Kohortenstudie. Es wurden alle Zwillingsschwangerschaften mit Verdacht auf PE und/oder HELLP-Syndrom eingeschlossen, bei denen die sFlt-1/PIGF-Ratio bestimmt wurde. Das Auftreten einer der folgenden Outcome-Parameter wurde als APO definiert: small for gestational age (SGA: Geburtsgewicht < 10. Perzentile), Atemnotsyndrom des Neugeborenen (RDS), Intubation, Aufnahme auf eine Intensivstation (NICU), arterieller Nabelschnur-pH-Wert < 7.20 oder 5-Minuten APGAR ≤7. ROC (receiver operating characteristic curves)-Analysen wurden durchgeführt, um den Vorhersagewert der sFlt-1/PlGF-Ratio bezüglich des Auftretens von APO zu überprüfen. Ergebnisse: 51 Zwillingsschwangerschaften wurden eingeschlossen. In 75% (38/51) der Fälle bestätigte sich die Diagnose einer PE und/oder eines HELLP-Syndroms. Der Mittelwert der sFlt-1/PIGF-Ratio war in der Gruppe mit APO höher (79.4 ± 65.5 vs. 60.1 ± 40.1), allerdings ohne statistische Signifikanz (p = 0.09). ROC-Analysen für die einzelnen APO-Parameter zeigten eine signifikante Assoziation der sFlt-1/PIGF-Ratio und einer postnatalen SGA-Situation (AUC = 0.753, 95% CI: 0.578 – 0.929, p = 0.005). Für die anderen APO Parameter konnte kein signifikanter Zusammenhang festgestellt werden. Diskussion: In Zwillingsschwangerschaften mit Verdacht auf PE und/oder HELLP-Syndrom kann die sFlt-1/PIGF-Ratio für die APO-Prädiktion hilfreich sein. Allerdings sind prospektive Studien erforderlich, um die genaue Rolle der sFlt-1/PlGF-Ratio bezogen auf die APO-Prädiktion in Zwillingsschwangerschaften zu definieren.

  • Myocardial function in fetuses with lower urinary tract obstruction: Is there a cardiac remodeling effect due to renal damage?

    by Oliver Graupner, Christian Enzensberger, Malena Götte, Aline Wolter, Vera Mueller, Andreea Kawecki, Stefanie Weber, Jan Degenhardt, Johannes Herrmann, Roland Axt‐Fliedner

    Objectives: Cardiac remodeling due to renal dysfunction may have an impact on myocardial function (MF) of fetuses with lower urinary tract obstruction (LUTO). The aim was to identify possible differences in MF in LUTO fetuses compared with healthy controls and to look for interactions between urine biochemistry and MF indices.Methods: This is a cohort study consisting of 31 LUTO fetuses and 45 healthy controls. Subgroups were generated according to intrauterine therapy (group 1: LUTO after therapy, group 2: LUTO without therapy at the time of examination, and group 3: controls). MF indices were measured using pulsed wave tissue Doppler imaging and M‐mode. Furthermore, results of fetal urine biochemistry were gathered retrospectively.Results: Among other findings, right ventricular (RV) e’/a’ ratio was lower in group 1 compared with group 3 (p = .050). According to gestational age (GA) level‐dependent analysis, RV isovolumetric relaxation time was significantly longer in group 2 compared with group 1 and group 3 at GA level 1 (19 wk of gestation). A significant positive correlation between RV e’/a’ ratio and β‐2‐microglobulin as well as α‐1‐microglobulin and potassium could be observed.Conclusion: We observed differences in MF and an association between ventricular filling pattern and renal protein secretion in LUTO fetuses. This can be interpreted as a sign of intrauterine cardiac remodeling.


  • Wall motion tracking in fetal echocardiography—Application of low and high frame rates for strain analysis

    by Christian Enzensberger, Laura Rostock, Oliver Graupner, Malena Götte, Aline Wolter, Carina Vorisek, Johannes Herrmann, Roland Axt‐Fliedner

    Objective: Compared to adults, fetal heart rates (HR) are elevated necessitating higher frame rates (FR) for strain analysis by speckle tracking echocardiography. The aim of this study was to investigate the influence of high FR compared to low FR on strain analysis in 2D speckle tracking.Methods: Fetal echocardiography was prospectively performed and acquired from the apical or basal four‐chamber views of the heart. Images were optimized for clear delineation of myocardial walls and stored in either raw Digital Imaging and Communications in Medicine (DICOM) cine‐loop format for offline analysis with a low FR of 60 frames per second (fps) or in the original FR (acoustic FR = AFR). For each loop, right (RV) and left (LV) ventricular fetal longitudinal peak systolic strain (LPSS) values were assessed by 2D Wall Motion tracking.Results: One hundred and three healthy fetuses were included with a mean gestational age of 26.3 ± 5.5 weeks. Mean AFR was 127 ± 26 fps. A mean FR/HR ratio was assessed of 0.42 and 0.90 between the low FR and AFR group, respectively. Relating to LPSS values, there was a significant difference between low FR and AFR for both ventricles (LV: −16.5% ± 3.9% (low FR) vs −13.6% ± 3.5% (AFR); and RV: −15.1% ± 3.6% (low FR) vs −12.6% ± 3.7% (AFR), both P < 0.001).Conclusions: Fetal LV and RV LPSS values derived with high AFR were significantly lower than corresponding LPSS values analyzed with low FR of 60 fps. Future studies are needed to clarify the clinical importance of this relationship.


  • Open Access

    Segmental Myocardial Displacement and Tissue Velocity Analysis of the Right Ventricle in Hypoplastic Left Heart Syndrome Fetuses and Controls Using Color Tissue Doppler Imaging (C-TDI)

    by Oliver Graupner, Christian Enzensberger, Larissa Wieg, Aline Wolter, Can Yerebakan, Markus Khalil, Roland Axt-Fliedner

    Introduction: The long-term outcome of patients with HLHS (hypoplastic left heart syndrome) is mainly determined by right ventricular function. Our study examines, whether there are differences in segmental right ventricular myocardial displacement and tissue velocities of fetuses with HLHS compared to healthy fetuses during gestation. Materials and methods: A prospective study was conducted including 20 fetuses with HLHS and 20 gestational age matched controls. c-TDI (colour tissue Doppler imaging) derived systolic and diastolic velocities as well as myocardial displacement were assessed in three different locations of the right ventricle (RV). A ROI (region of interest) was placed in the basal, middle and apical part of the myocardium. Possible changes of c-TDI indices in the course of pregnancy and between the three different segments were investigated in both groups. Results: HLHS fetuses showed significantly lower e' velocities measured in the basal and middle part of the RV compared to healthy controls (p < 0.05). Basal displacement showed significantly lower values in HLHS fetuses compared to controls. In control fetuses but not in HLHS fetuses there was a significant increase of basal diastolic velocities and displacement in the course of pregnancy. According to myocardial velocities and displacement values there was a significant decrease from the base of the fetal heart to the apex pointed in both groups. Conclusions: An altered right ventricular myocardial function in HLHS fetuses within different myocardial segments could be demonstrated. An apicobasal gradient with higher velocity and displacement values in the basal part of RV myocardium could be found in both groups. The technique may be of value in the prenatal assessment of myocardial function, however its role as a monitoring tool and outcome predictor needs to be defined.


  • Absent pulmonary valve syndrome - diagnosis, associations, and outcome in 71 prenatally diagnosed cases

    by Roland Axt-Fliedner, Andrii Kurkevych, Maciej Slodki, Maria Respondek-Liberska, Katarzyna Zych-Krekora, Rüdiger Stressig, Jochen Ritgen, Guiseppe Rizzo, Martin Krapp, Luc de Catte, et al.

    The objective of this study was to analyze the spectrum of prenatally diagnosed absent pulmonary valve syndrome (APVS) and the outcome from diagnosis onwards. Fetuses with APVS and tetralogy of Fallot (TOF/APVS) and with APVS and intact ventricular septum (APVS/IVS) were included. Multicenter retrospective study of the International Prenatal Cardiology Collaboration Group. Clinical and echocardiographic databases of nine referral centers were reviewed from 2012–2016. The cohort included 71 cases, 59 with TOF/APVS and 12 with APVS/IVS. In 18.3% of cases, diagnosis was achieved within first trimester. Association with hydrops fetalis was high within first trimester (69%). No fetus with known outcome survived after first trimester diagnosis. Karyotype anomalies occurred in 45% of cases with known karyotype. Intrauterine fetal demise occurred in 14.3%. Overall survival after initial diagnosis in the total cohort was 28.1% (28.8% TOF/APVS and 25.0% APVS/IVS). Survival to birth was 50% in TOF/APVS and 44.4% in APVS/IVS. Survival of subjects born alive beyond neonatal period was 84.6% in TOF/APVS and 100% in APVS/IVS. Diagnosis of APVS is feasible within first trimester. Outcomes remain guarded, especially if first trimester diagnosis is included into the analysis because of associated karyotypic anomalies, the presence of hydrops fetalis, and patent ductus arteriosus. © 2017 John Wiley & Sons, Ltd.